Lv1
58 积分 2025-01-01 加入
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
6天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
8天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
9天前
已完结
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
10天前
已完结
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
10天前
已完结
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
13天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
14天前
已完结
Pembrolizumab in HER2-Positive Gastric Cancer
14天前
已完结
William David Coolidge: October 23, 1873-February 3, 1975
14天前
已关闭
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
21天前
已完结
皖公网安备34019202002308
